ABBOTT LABORATORIES (NASDAQ:ABT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Abbott today announced that Thomas C. Freyman, Executive Vice President, Finance and Administration, informed Abbott on December 8, 2016 that he plans to retire from the company after 38 years of service, effective February 1, 2017.
About ABBOTT LABORATORIES (NASDAQ:ABT)